Forlong Biotechnology
- Biotech or pharma, therapeutic R&D
Clinical-stage biotech company developing cancer therapies based on cytokines engineered with proprietary platforms. Lead Assets: IL-15 in Phase I and IL-18 in Preclinical Stage
June 16-19, 2025
Boston Convention & Exhibition Center
BIO DOUBLE HELIX SPONSORS
Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.
)
)
)
)
){kind=logo}
){kind=logo}
)
BIO HELIX SPONSORS
){kind=logo}
)
){kind=logo}
){kind=logo}